Eric Lefkofsky is the new Father Time
Tempus is a Latin word meaning time. That is what Eric Lefkofsky is giving to the world, more time. The Chicago start-up, Tempus, founded in 2015, comes out of the camp of one of the 2021 most affluent people. Tempus raised $8.1 billion in funding in 2020. As Eric Lefkofsky explains, the artificial intelligence precision medicine innovator has released a revolutionary device that allows voice-enabled real-time data and insight at an oncologist’s fingertips.
This advancement to precision medicine by Lefkofsky’s artificial intelligence clarifies complex issues. The Tempus One is organizing and managing data, reducing response time, and making it easier for analysis. As Eric Lefkofsky points out, the device has the world’s largest library of clinical and molecular data. The operating system and a predictive algorithm make the data useful and accessible.
Tempus One enables physicians to give a higher quality of patient care through time management and a knowledge base on demand. Optimizing therapeutic development, discovery, and delivery unparallelled. Eric Lefkofsky adds that by providing the current doctor with past history and treatment, collecting data, and cross-referencing. Allowing for more well-rounded care.
The new, Google-backed company is looking to debut on the stock market as early as 2022 though plans could change and timelines shifted. The company is beefing up its backers and leadership team with resumes with weight. Tempus is partnering with Cedars-Sinai to develop personalized treatment using virtual replicas of patients’ DNA, RNA, and protein. Eric Lefkofsky understands the responsibility he and Tempus are undertaking now that the technological backing is developed. He hopes to give people more time by eradicating diseases.